MyAverix Finance
US · Healthcare
Aryx Therapeutics I (ARYX)
Drug Manufacturers - Specialty & Generic
Aryx Therapeutics I (ARYX) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ARYX
Aryx Therapeutics I (ARYX) — FAQ
What is ARYX's P/E ratio?
The price-to-earnings (P/E) ratio for Aryx Therapeutics I (ARYX) is 18.00 (data as of 2026-03-23).
Does Aryx Therapeutics I pay a dividend?
Dividend yield is not available in the current snapshot for Aryx Therapeutics I (ARYX). Check the MyAverix Finance app for the latest dividend data.
What sector is Aryx Therapeutics I in?
Aryx Therapeutics I (ARYX) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is ARYX listed on?
ARYX is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.